{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:09:24Z","timestamp":1784563764346,"version":"3.55.0"},"reference-count":114,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Oral anticoagulation (OAC) is essential for preventing ischemic stroke events in patients with atrial fibrillation (AF), and leads to a significant ischemic prophylaxis, when appropriately used. However, there is still a risk of experiencing stroke events, despite being under anticoagulation. Stroke despite OAC is an increasingly common diagnosis, and pathophysiologically, it can be associated with several etiologies, ranging from AF competing mechanisms to true anticoagulation failure. While the cardioembolic origin of stroke is the most frequently identified etiology, other factors also have to be considered, as there is a significance risk of coexistence. This highlights the need for thorough diagnostic testing, evaluating each stroke etiology independently, with the use of imaging, biomarker and blood tests. Treating such patients, however, is more complex, as there is still uncertainty regarding the selection of OAC post-stroke, with data showing a superiority of direct OAC (DOAC), compared to vitamin K antagonists, in recurrent ischemic stroke prevention and conflicting results regarding OAC switch. Finally, the additive value of cardiac interventions, such as left atrial appendage occlusion (LAAO), in secondary prevention of stroke, is being explored, as it could potentially lead to significant stroke risk reduction. This review, therefore, provides an updated summary of the pathophysiology, diagnostics and therapeutics of stroke under OAC, while also discussing the future direction on the Achilles heel of AF management.<\/jats:p>","DOI":"10.3390\/brainsci15050454","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T07:49:36Z","timestamp":1745912976000},"page":"454","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ischemic Stroke in Patients Under Oral Anticoagulation: The Achilles Heel of Atrial Fibrillation Management"],"prefix":"10.3390","volume":"15","author":[{"given":"Kyriakos","family":"Dimitriadis","sequence":"first","affiliation":[{"name":"First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0401-9473","authenticated-orcid":false,"given":"Nikolaos","family":"Pyrpyris","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0706-4424","authenticated-orcid":false,"given":"Konstantinos","family":"Aznaouridis","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6808-7163","authenticated-orcid":false,"given":"Gyanaranjan","family":"Nayak","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6678-6240","authenticated-orcid":false,"given":"Panagiotis","family":"Kanatas","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9260-6306","authenticated-orcid":false,"given":"Panagiotis","family":"Theofilis","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1100-7430","authenticated-orcid":false,"given":"Panagiotis","family":"Tsioufis","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0464-3607","authenticated-orcid":false,"given":"Eirini","family":"Beneki","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, 115 27 Athens, Greece"},{"name":"Department of Cardiology, Lausanne University Hospital and University of Lausanne, 1005 Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2726-9520","authenticated-orcid":false,"given":"Aggelos","family":"Papanikolaou","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5598-9950","authenticated-orcid":false,"given":"Christos","family":"Fragoulis","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina","family":"Aggeli","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7636-6725","authenticated-orcid":false,"given":"Konstantinos","family":"Tsioufis","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/CIRCRESAHA.120.316340","article-title":"Epidemiology of Atrial Fibrillation in the 21st Century","volume":"127","author":"Kornej","year":"2020","journal-title":"Circ. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/jce.15351","article-title":"Atrial Fibrillation Incidence, Prevalence, Predictors, and Adverse Outcomes in Acute Coronary Syndromes: A Pooled Analysis of Data from 8 Million Patients","volume":"33","author":"Noubiap","year":"2022","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1161\/STROKEAHA.115.012004","article-title":"Atrial Fibrillation and Mechanisms of Stroke","volume":"47","author":"Kamel","year":"2016","journal-title":"Stroke"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation Developed in Collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/heartjnl-2019-314898","article-title":"Stroke and Thromboembolism Prevention in Atrial Fibrillation","volume":"106","author":"Jame","year":"2020","journal-title":"Heart"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","article-title":"Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex","volume":"145","author":"Carnicelli","year":"2022","journal-title":"Circulation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-Analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1161\/STROKEAHA.116.013540","article-title":"Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events","volume":"47","author":"Rost","year":"2016","journal-title":"Stroke"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1136\/jnnp-2020-323963","article-title":"Ischaemic Stroke in Anticoagulated Patients with Atrial Fibrillation","volume":"92","author":"Stretz","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Garcia, C., Silva, M., Ara\u00fajo, M., Henriques, M., Margarido, M., Vicente, P., Nzwalo, H., and Macedo, A. (2022). Admission Severity of Atrial-Fibrillation-Related Acute Ischemic Stroke in Patients under Anticoagulation Treatment: A Systematic Review and Meta-Analysis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11123563"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/ene.13405","article-title":"The Relationship between Stroke Severity and Prior Direct Oral Anticoagulant Therapy in Patients with Acute Ischaemic Stroke and Non-valvular Atrial Fibrillation","volume":"24","author":"Sakamoto","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of Subtype of Acute Ischemic Stroke. Definitions for Use in a Multicenter Clinical Trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/jnnp-2021-328391","article-title":"Aetiology, Secondary Prevention Strategies and Outcomes of Ischaemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation","volume":"93","author":"Polymeris","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/23969873231185220","article-title":"The Impact of Competing Stroke Etiologies in Patients with Atrial Fibrillation","volume":"8","author":"Zietz","year":"2023","journal-title":"Eur. Stroke J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/23969873231168367","article-title":"The Contribution of Competing Mechanisms in Stroke despite Anticoagulation in Patients with Atrial Fibrillation","volume":"8","author":"Herlekar","year":"2023","journal-title":"Eur. Stroke J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/NRL.0000000000000504","article-title":"Characteristics and Mechanism of Acute Ischemic Stroke in NAVF Patients With Prior Oral Anticoagulant Therapy","volume":"28","author":"Xue","year":"2023","journal-title":"Neurologist"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/STROKEAHA.119.025350","article-title":"Causes and Risk Factors of Cerebral Ischemic Events in Patients with Atrial Fibrillation Treated With Non\u2013Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention","volume":"50","author":"Paciaroni","year":"2019","journal-title":"Stroke"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/jnnp-2021-326166","article-title":"Ischaemic Stroke on Anticoagulation Therapy and Early Recurrence in Acute Cardioembolic Stroke: The IAC Study","volume":"92","author":"Yaghi","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1161\/STROKEAHA.119.027275","article-title":"Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke","volume":"51","author":"Tanaka","year":"2020","journal-title":"Stroke"},{"key":"ref_21","first-page":"e358","article-title":"Association of Alternative Anticoagulation Strategies and Outcomes in Patients With Ischemic Stroke While Taking a Direct Oral Anticoagulant","volume":"101","author":"Ip","year":"2023","journal-title":"Neurology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1538-7836.2012.04649.x","article-title":"INR Targets and Site-level Anticoagulation Control: Results from the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)","volume":"10","author":"Rose","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e005969","DOI":"10.1161\/CIRCOUTCOMES.119.005969","article-title":"Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation","volume":"13","author":"Ozaki","year":"2020","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e021601","DOI":"10.1161\/JAHA.121.021601","article-title":"Long-Term Medication Adherence Trajectories to Direct Oral Anticoagulants and Clinical Outcomes in Patients With Atrial Fibrillation","volume":"10","author":"An","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s42466-023-00247-7","article-title":"Large-Vessel-Occlusion in Patients with Previous Ischemic Stroke: An Analysis of Adherence to Secondary Preventive Medication for Different Etiologies","volume":"5","author":"Kohlhase","year":"2023","journal-title":"Neurol. Res. Pract."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1080\/07853890.2021.1968031","article-title":"Adherence to Oral Anticoagulation in Ischemic Stroke Patients with Atrial Fibrillation","volume":"53","author":"Tiili","year":"2021","journal-title":"Ann. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e031281","DOI":"10.1161\/JAHA.123.031281","article-title":"Association of Depression and Adherence to Oral Anticoagulation in Patients With Atrial Fibrillation","volume":"12","author":"Lapa","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.03.005","article-title":"Therapeutic Decisions in Atrial Fibrillation for Stroke Prevention: The Role of Aversion to Ambiguity and Physicians\u2019 Risk Preferences","volume":"27","author":"Sposato","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2147\/PPA.S143958","article-title":"Aversion to Ambiguity and Willingness to Take Risks Affect Therapeutic Decisions in Managing Atrial Fibrillation for Stroke Prevention: Results of a Pilot Study in Family Physicians","volume":"11","author":"Raptis","year":"2017","journal-title":"Patient Prefer. Adherence"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Bernal, C.L., Sanchez-Saez, F., Bejarano-Quisoboni, D., Riera-Arnau, J., Sanf\u00e9lix-Gimeno, G., and Hurtado, I. (2021). Real-World Management and Clinical Outcomes of Stroke Survivors With Atrial Fibrillation: A Population-Based Cohort in Spain. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.789783"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/pds.4194","article-title":"Quality of Warfarin Therapy and Risk of Stroke, Bleeding, and Mortality among Patients with Atrial Fibrillation: Results from the Nationwide FinWAF Registry","volume":"26","author":"Lehto","year":"2017","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/ana.25165","article-title":"Rivaroxaban Plasma Levels in Acute Ischemic Stroke and Intracerebral Hemorrhage","volume":"83","author":"Seiffge","year":"2018","journal-title":"Ann. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e024402","DOI":"10.1161\/JAHA.121.024402","article-title":"Association Between Inappropriately Dosed Anticoagulation Therapy With Stroke Severity and Outcomes in Patients With Atrial Fibrillation","volume":"11","author":"Vinding","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/bcp.14127","article-title":"Impact of Direct Oral Anticoagulant Off-label Doses on Clinical Outcomes of Atrial Fibrillation Patients: A Systematic Review","volume":"86","author":"Santos","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s00415-019-09412-y","article-title":"Stroke Severity in Patients with Preceding Direct Oral Anticoagulant Therapy as Compared to Vitamin K Antagonists","volume":"266","author":"Auer","year":"2019","journal-title":"J. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1161\/STROKEAHA.109.573907","article-title":"Racial Disparities in Awareness and Treatment of Atrial Fibrillation","volume":"41","author":"Meschia","year":"2010","journal-title":"Stroke"},{"key":"ref_37","first-page":"103","article-title":"Race\/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data","volume":"112","author":"Essien","year":"2020","journal-title":"J. Natl. Med. Assoc."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/phar.2158","article-title":"Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, 2010\u20132017","volume":"38","author":"Zhu","year":"2018","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Gurusamy, V.K., Brobert, G., Vora, P., and Friberg, L. (2019). Sociodemographic Factors and Choice of Oral Anticoagulant in Patients with Non-Valvular Atrial Fibrillation in Sweden: A Population-Based Cross-Sectional Study Using Data from National Registers. BMC Cardiovasc. Disord., 19.","DOI":"10.1186\/s12872-019-1029-z"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.amjcard.2014.12.022","article-title":"Risk Stratification and Stroke Prevention Therapy Care Gaps in Canadian Atrial Fibrillation Patients (from the Co-Ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation Chart Audit)","volume":"115","author":"Patel","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/ehjcvp\/pvaa103","article-title":"Off-Label Use of Reduced Dose Direct Oral Factor Xa Inhibitors in Subjects with Atrial Fibrillation: A Review of Clinical Evidence","volume":"7","author":"Bo","year":"2021","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Shen, N.-N., Zhang, C., Hang, Y., Li, Z., Kong, L.-C., Wang, N., Wang, J.-L., and Gu, Z.-C. (2021). Real-World Prevalence of Direct Oral Anticoagulant Off-Label Doses in Atrial Fibrillation: An Epidemiological Meta-Analysis. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.581293"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijcard.2022.04.062","article-title":"Clinical Effects of Off-Label Reduced Doses of Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis","volume":"362","author":"Pereira","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/jth.13268","article-title":"The Effect of Carbamazepine on Warfarin Anticoagulation: A Register-based Nationwide Cohort Study Involving the Swedish Population","volume":"14","author":"Mannheimer","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s40262-015-0283-1","article-title":"Pharmacokinetic Drug Interaction Studies with Enzalutamide","volume":"54","author":"Gibbons","year":"2015","journal-title":"Clin. Pharmacokinet."},{"key":"ref_46","first-page":"e007956","article-title":"Drug Interactions Affecting Oral Anticoagulant Use","volume":"15","author":"Mar","year":"2022","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Ferri, N., Colombo, E., Tenconi, M., Baldessin, L., and Corsini, A. (2022). Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14061120"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"100137","DOI":"10.1016\/j.rpth.2023.100137","article-title":"Drug-Drug Interactions between Direct Oral Anticoagulants and Anticonvulsants and Clinical Outcomes: A Systematic Review","volume":"7","author":"Candeloro","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e066846","DOI":"10.1136\/bmjopen-2022-066846","article-title":"Drug\u2013Drug Interaction between Dexamethasone and Direct-Acting Oral Anticoagulants: A Nested Case\u2013Control Study in the National COVID Cohort Collaborative (N3C)","volume":"12","author":"Kravchenko","year":"2022","journal-title":"BMJ Open"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s11239-021-02561-w","article-title":"Direct Oral Anticoagulant Plasma Levels in Hospitalized COVID-19 Patients Treated with Dexamethasone","volume":"53","author":"Potere","year":"2022","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Grze\u015bk, G., Rogowicz, D., Wo\u0142owiec, \u0141., Ratajczak, A., Gilewski, W., Chudzi\u0144ska, M., Sinkiewicz, A., and Banach, J. (2021). The Clinical Significance of Drug\u2013Food Interactions of Direct Oral Anticoagulants. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168531"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1017\/cjn.2024.3","article-title":"Characteristics of Ischemic Stroke Despite Oral Anticoagulant Use For Atrial Fibrillation","volume":"51","author":"Ducroux","year":"2024","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa2407794","article-title":"Continuation versus Interruption of Oral Anticoagulation during TAVI","volume":"392","author":"Bor","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/jth.14598","article-title":"Scientific and Standardization Committee Communication: Guidance Document on the Periprocedural Management of Patients on Chronic Oral Anticoagulant Therapy: Recommendations for Standardized Reporting of Procedural\/Surgical Bleed Risk and Patient-specific Thromboembolic Risk","volume":"17","author":"Spyropoulos","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e022478","DOI":"10.1136\/bmjopen-2018-022478","article-title":"Risk Factors for Thromboembolic and Bleeding Events in Anticoagulated Patients with Atrial Fibrillation: The Prospective, Multicentre Observational PREvention oF Thromboembolic Events\u2014European Registry in Atrial Fibrillation (PREFER in AF)","volume":"9","author":"Rohla","year":"2019","journal-title":"BMJ Open"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.25700","article-title":"Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation","volume":"87","author":"Seiffge","year":"2020","journal-title":"Ann. Neurol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e006402","DOI":"10.1161\/JAHA.117.006402","article-title":"Left Atrial Size and Long-Term Risk of Recurrent Stroke After Acute Ischemic Stroke in Patients with Nonvalvular Atrial Fibrillation","volume":"6","author":"Ogata","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/00015385.2021.2005307","article-title":"Prevalence and Predictors of Left Atrial Thrombosis in Atrial Fibrillation Patients Treated with Non-Vitamin K Antagonist Oral Anticoagulants","volume":"78","author":"Angelini","year":"2023","journal-title":"Acta Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s10554-020-01811-x","article-title":"Left Atrial Thrombus in Patients with Atrial Fibrillation and under Oral Anticoagulant Therapy; 3-D Transesophageal Echocardiographic Study","volume":"36","author":"Durmaz","year":"2020","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijcard.2017.07.048","article-title":"NOACs and Atrial Fibrillation: Incidence and Predictors of Left Atrial Thrombus in the Real World","volume":"249","author":"Bertaglia","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.echo.2012.01.012","article-title":"Prognostic Value of Low Left Atrial Appendage Wall Velocity in Patients with Ischemic Stroke and Atrial Fibrillation","volume":"25","author":"Tamura","year":"2012","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Wang, F., Zhu, M., Wang, X., Zhang, W., Su, Y., Lu, Y., Pan, X., Gao, D., Zhang, X., and Chen, W. (2018). Predictive Value of Left Atrial Appendage Lobes on Left Atrial Thrombus or Spontaneous Echo Contrast in Patients with Non-Valvular Atrial Fibrillation. BMC Cardiovasc. Disord., 18.","DOI":"10.1186\/s12872-018-0889-y"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/jce.14922","article-title":"Left Atrial Appendage Morphology Predicts the Formation of Left Atrial Appendage Thrombus","volume":"32","author":"Negrotto","year":"2021","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5853\/jos.2014.16.3.131","article-title":"Magnetic Resonance Imaging in Acute Ischemic Stroke Treatment","volume":"16","author":"Kim","year":"2014","journal-title":"J. Stroke"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1590\/1980-57642016dn11-040002","article-title":"Neuroimaging in Cerebral Small Vessel Disease: Update and New Concepts","volume":"11","author":"Shibuya","year":"2017","journal-title":"Dement. Neuropsychol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.21456","article-title":"Admission International Normalized Ratio and Acute Infarct Volume in Ischemic Stroke","volume":"64","author":"Ay","year":"2008","journal-title":"Ann. Neurol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e010593","DOI":"10.1161\/JAHA.118.010593","article-title":"Prior Anticoagulation and Short- or Long-Term Clinical Outcomes in Ischemic Stroke or Transient Ischemic Attack Patients With Nonvalvular Atrial Fibrillation","volume":"8","author":"Tokunaga","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.chest.2016.08.1462","article-title":"Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants","volume":"151","author":"Samuelson","year":"2017","journal-title":"Chest"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/jth.12149","article-title":"Measuring Oral Direct Inhibitors of Thrombin and Factor Xa: A Recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis","volume":"11","author":"Baglin","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Sahli, S.D., Castellucci, C., Roche, T.R., R\u00f6ssler, J., Spahn, D.R., and Kaserer, A. (2022). The Impact of Direct Oral Anticoagulants on Viscoelastic Testing\u2014A Systematic Review. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.991675"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"f72","DOI":"10.1093\/ehjcvp\/pvaa017","article-title":"Long-Term Persistence and Adherence with Non-Vitamin K Oral Anticoagulants in Patients with Atrial Fibrillation and Their Associations with Stroke Risk","volume":"7","author":"Komen","year":"2021","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2022.07.034","article-title":"Elevated 8-Isoprostane Concentration Is Associated with Thromboembolic Events in Patients with Atrial Fibrillation","volume":"365","author":"Chmiel","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Behnoush, A.H., Khalaji, A., Bahiraie, P., and Gupta, R. (2023). Meta-Analysis of Outcomes Following Intravenous Thrombolysis in Patients with Ischemic Stroke on Direct Oral Anticoagulants. BMC Neurol., 23.","DOI":"10.1186\/s12883-023-03498-8"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/STROKEAHA.119.026426","article-title":"Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants","volume":"51","author":"Shahjouei","year":"2020","journal-title":"Stroke"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1007\/s00415-023-11815-x","article-title":"Safety and Efficacy of Intravenous Thrombolysis in Patients with Acute Ischemic Stroke Taking Direct Oral Anticoagulants Prior to Stroke: A Meta-Analysis","volume":"270","author":"Liang","year":"2023","journal-title":"J. Neurol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1001\/jamaneurol.2022.4782","article-title":"Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants","volume":"80","author":"Meinel","year":"2023","journal-title":"JAMA Neurol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ana.25917","article-title":"Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation","volume":"89","author":"Meinel","year":"2021","journal-title":"Ann. Neurol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000493801","article-title":"Safety of Endovascular Thrombectomy for Acute Ischaemic Stroke in Anticoagulated Patients Ineligible for Intravenous Thrombolysis","volume":"46","author":"Wong","year":"2018","journal-title":"Cerebrovasc. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12959-022-00394-y","article-title":"Safety and Efficacy of Endovascular Thrombectomy in Acute Ischemic Stroke Treated with Anticoagulants: A Systematic Review and Meta-Analysis","volume":"20","author":"Chen","year":"2022","journal-title":"Thromb. J."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/STROKEAHA.115.008891","article-title":"Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation","volume":"46","author":"Paciaroni","year":"2015","journal-title":"Stroke"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1177\/23969873211042192","article-title":"European Stroke Organisation and European Academy of Neurology Joint Guidelines on Post-Stroke Cognitive Impairment","volume":"6","author":"Quinn","year":"2021","journal-title":"Eur. Stroke J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.neuron.2020.01.039","article-title":"Advanced Neurotechnologies for the Restoration of Motor Function","volume":"105","author":"Micera","year":"2020","journal-title":"Neuron"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Aremu, T.O., Oluwole, O.E., Adeyinka, K.O., and Schommer, J.C. (2022). Medication Adherence and Compliance: Recipe for Improving Patient Outcomes. Pharmacy, 10.","DOI":"10.3390\/pharmacy10050106"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11239-017-1565-2","article-title":"High Number of Newly Initiated Direct Oral Anticoagulant Users Switch to Alternate Anticoagulant Therapy","volume":"44","author":"Manzoor","year":"2017","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Fastner, C., Szabo, K., Samartzi, M., Kruska, M., Akin, I., Platten, M., Baumann, S., and Alonso, A. (2022). Treatment Standards for Direct Oral Anticoagulants in Patients with Acute Ischemic Stroke and Non-Valvular Atrial Fibrillation: A Survey among German Stroke Units. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0264122"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1161\/STROKEAHA.121.038239","article-title":"Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study","volume":"53","author":"Paciaroni","year":"2022","journal-title":"Stroke"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e029979","DOI":"10.1161\/JAHA.123.029979","article-title":"Comparing Efficacy and Safety Between Patients With Atrial Fibrillation Taking Direct Oral Anticoagulants or Warfarin After Direct Oral Anticoagulant Failure","volume":"12","author":"Hsieh","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial Fibrillation","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy","volume":"64","author":"Holmes","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","article-title":"Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke","volume":"384","author":"Whitlock","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1161\/CIRCULATIONAHA.122.060315","article-title":"Oral Anticoagulation Use and Left Atrial Appendage Occlusion in LAAOS III","volume":"148","author":"Connolly","year":"2023","journal-title":"Circulation"},{"key":"ref_92","first-page":"28","article-title":"Left Atrial Appendage Occlusion for Stroke despite Oral Anticoagulation (Resistant Stroke). Results from the Amplatzer Cardiac Plug Registry","volume":"73","author":"Freixa","year":"2020","journal-title":"Rev. Espa\u00f1ola Cardiolog\u00eda (Engl. Ed.)"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijcard.2022.02.030","article-title":"Residual Stroke Risk after Left Atrial Appendage Closure in Patients with Prior Oral Anticoagulation Failure","volume":"354","author":"Bangalore","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/joa3.12838","article-title":"Left Atrial Appendage Occlusion after Thromboembolic Events or Left Atrial Appendage Sludge during Anticoagulation Therapy: Is Two Better than One? Real-world Experience from a Tertiary Care Hospital","volume":"39","author":"Margonato","year":"2023","journal-title":"J. Arrhythm."},{"key":"ref_95","first-page":"212","article-title":"Left Atrial Appendage Occlusion as Adjunctive Therapy to Anticoagulation for Stroke Recurrence","volume":"31","author":"Freixa","year":"2019","journal-title":"J. Invasive Cardiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/17843286.2020.1821494","article-title":"Left Atrial Appendage Occlusion in Recurrent Ischaemic Stroke, a Multicentre Experience","volume":"77","author":"Galloo","year":"2022","journal-title":"Acta Clin. Belg."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/ene.13894","article-title":"Oral Anticoagulation and Left Atrial Appendage Closure: A New Strategy for Recurrent Cardioembolic Stroke","volume":"26","author":"Masjuan","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"ref_98","first-page":"1311","article-title":"Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication","volume":"17","author":"Aarnink","year":"2024","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/jamaneurol.2024.2882","article-title":"Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation","volume":"81","author":"Maarse","year":"2024","journal-title":"JAMA Neurol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1474-4422(24)00037-1","article-title":"Secondary Stroke Prevention in People with Atrial Fibrillation: Treatments and Trials","volume":"23","author":"Seiffge","year":"2024","journal-title":"Lancet Neurol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.02.022","article-title":"Genetic and Non-Genetic Factors Affecting the Quality of Anticoagulation Control and Vascular Events in Atrial Fibrillation","volume":"26","author":"Park","year":"2017","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5414\/CP202494","article-title":"Warfarin Dose Requirement with Different Genotypes of Polymorphisms on CYP2C9 and VKORC1 and Indications in Han-Chinese Patients","volume":"55","author":"Chen","year":"2017","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/GIM.0b013e31820ad77d","article-title":"A Randomized Controlled Trial of Genotype-Based Coumadin Initiation","volume":"13","author":"Burmester","year":"2011","journal-title":"Genet. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/CIRCULATIONAHA.112.001233","article-title":"Genetic Determinants of Dabigatran Plasma Levels and Their Relation to Bleeding","volume":"127","author":"Eriksson","year":"2013","journal-title":"Circulation"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Raymond, J., Imbert, L., Cousin, T., Duflot, T., Varin, R., Wils, J., and Lamoureux, F. (2021). Pharmacogenetics of Direct Oral Anticoagulants: A Systematic Review. J. Pers. Med., 11.","DOI":"10.3390\/jpm11010037"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/cpt.2316","article-title":"Pharmacogenetics of Bleeding and Thromboembolic Events in Direct Oral Anticoagulant Users","volume":"110","author":"Vuorinen","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/ehjcvp\/pvae002","article-title":"Pharmacological and Clinical Appraisal of Factor XI Inhibitor Drugs","volume":"10","author":"Occhipinti","year":"2024","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jacc.2019.04.035","article-title":"Permanent Percutaneous Carotid Artery Filter to Prevent Stroke in Atrial Fibrillation Patients","volume":"74","author":"Reddy","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/STROKEAHA.115.012325","article-title":"Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients","volume":"47","author":"Shah","year":"2016","journal-title":"Stroke"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1161\/STROKEAHA.111.000402","article-title":"Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation","volume":"44","author":"Harrington","year":"2013","journal-title":"Stroke"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/eurheartj\/ehab847","article-title":"Cost-Effectiveness Analysis of Left Atrial Appendage Occlusion in Patients with Atrial Fibrillation and Contraindication to Oral Anticoagulation","volume":"43","author":"Labori","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1016\/j.jacc.2015.09.084","article-title":"Time to Cost-Effectiveness Following Stroke Reduction Strategies in AF","volume":"66","author":"Reddy","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e011577","DOI":"10.1161\/JAHA.118.011577","article-title":"Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5-Year, Long-Term Data","volume":"8","author":"Reddy","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"106438","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106438","article-title":"Clinical Outcomes and Costs of Recurrent Ischemic Stroke: A Systematic Review","volume":"31","author":"Ferrone","year":"2022","journal-title":"J. Stroke Cerebrovasc. Dis."}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/15\/5\/454\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:22:21Z","timestamp":1760030541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/15\/5\/454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":114,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["brainsci15050454"],"URL":"https:\/\/doi.org\/10.3390\/brainsci15050454","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,26]]}}}